首页> 外文期刊>Journal of Clinical Oncology >False-Positive [~18F]Fluorodeoxyglucose-Avid Lymph Nodes on Positron Emission Tomography-Computed Tomography After Allogeneic but Not Autologous Stem-Cell Transplantation in Patients With Lymphoma
【24h】

False-Positive [~18F]Fluorodeoxyglucose-Avid Lymph Nodes on Positron Emission Tomography-Computed Tomography After Allogeneic but Not Autologous Stem-Cell Transplantation in Patients With Lymphoma

机译:同种异体但非自体干细胞移植后正电子发射断层扫描计算机断层扫描上的假阳性[〜18F]氟去氧葡萄糖-Avid淋巴结转移

获取原文
获取原文并翻译 | 示例
           

摘要

Determine the clinical significance of [~18F]fluorodeoxyglucose (FDG)-avid lesions in patients with lymphoma treated with stem-cell transplantation.MethodsAll patients who underwent stem-cell transplantation for lymphoma at Memorial Sloan-Kettering Cancer Center between January 2005 and December 2009 and had post-transplantation FDG positron emission tomography/computed tomography (PET/CT) examinations were included. PET/CT examinations were evaluated for FDG-avid lesions suggestive of disease. Clinical records, biopsy results, and subsequent imaging examinations were evaluated for malignancy.Results Two hundred fifty-one patients were identified, 107 with allogeneic and 144 with autologous stem-cell transplantation. Of allogeneic stem-cell transplantation recipients, 50 had FDG-avid lesions suggestive of lymphoma, defined as FDG-avidity greater than liver background. However, only 29 of these 50 demonstrated lymphoma on biopsy, whereas biopsy attempts were benign in the other 21 patients. Sensitivity analysis determined that a 1.5-cm short axis nodal measurement distinguished patients with malignant from nonmalignant biopsies. In 21 of 22 patients with FDG-avid lymph nodes <= 1.5 cm, biopsy attempts were benign. In the absence of treatment, these nodes either resolved or were stable on repeat imaging. Disease-free survival of patients with FDG-avid <= 1,5 cm lymph nodes was comparable with patients without FDG-avid lesions. In comparison, autologous stem-cell transplantation patients rarely demonstrated FDG-avid lesions suggestive of disease without malignant pathology.Conclusion Twenty percent (21 of 107) of patients with an ailogeneic stem-cell transplantation demonstrated FDG-avid lymph nodes up to 1.5 cm in short axis on PET/CT, which did not represent active lymphoma. After allogeneic stem-cell transplantation of patients with lymphoma, benign FDG-avid <= 1.5 cm lymph nodes can mimic malignancy.
机译:确定[〜18F]氟脱氧葡萄糖(FDG)-avid病变在干细胞移植治疗的淋巴瘤患者中的临床意义。方法2005年1月至2009年12月在纪念斯隆-凯特琳癌症中心接受干细胞移植治疗的所有患者并进行了移植后FDG正电子发射断层扫描/计算机断层扫描(PET / CT)检查。对PET / CT检查评估了FDG-avid病变提示疾病。结果对250例患者进行了鉴定,其中107例为同种异体患者,144例为自体干细胞移植,对恶性肿瘤进行了评估。在同种异体干细胞移植受者中,有50名具有FDG-avid病变提示淋巴瘤,定义为FDG-avidity大于肝脏背景。但是,这50例中只有29例在活检中表现出淋巴瘤,而在其他21例患者中,活检尝试是良性的。敏感性分析确定1.5厘米的短轴淋巴结测量可以区分恶性和非恶性活检患者。在22例FDG-avid淋巴结<= 1.5厘米的患者中,有21例活检未见异常。在不进行治疗的情况下,这些淋巴结在重复成像中均已消退或稳定。 FDG-avid <= 1.5 cm淋巴结的无病生存率与无FDG-avid病变的患者相当。相比之下,自体干细胞移植患者很少表现出FDG-avid病变提示无恶性病变的疾病。结论20%(107人中的21人)进行了非遗传性干细胞移植的患者显示,FDG-avid淋巴结可达1.5 cm。 PET / CT上的短轴,不代表活动性淋巴瘤。异基因干细胞移植后的淋巴瘤患者,良性FDG-avid <= 1.5 cm淋巴结可以模拟恶性肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号